Yair Einhorn
@yaireinhorn
Science & Innovation. Special interest in BioTech, Pharma, Gene Editing & CRISPR 🧬. Also sharing my thoughts on the Financial Markets & the Global Economy. 📈
ID: 1238780417324580867
14-03-2020 10:54:12
18,18K Tweet
13,13K Takipçi
46 Takip Edilen
Prime Medicine 4/Prime Medicine has already presented an impressive Preclinical data - during #ASGCT2023, for its leading Ex-Vivo program – PM359 for the treatment of patients with chronic granulomatous disease CGD. Here’s a 🧵which I have written shortly after $PRME presentation👇